<!DOCTYPE html>
<html lang="en">

<head>
  <title>DM | The Peripheral Brain</title>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <script src='https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.2/MathJax.js?config=TeX-MML-AM_CHTML'></script>
  <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.3.1/jquery.min.js"></script>

  <link rel="stylesheet" href="/peripheral_brain/css/main.css" />
  <link rel="stylesheet" href="/peripheral_brain/css/mobile.css" />
  <link rel="stylesheet" href="/peripheral_brain/css/buttons.css" />

  
    <link rel="stylesheet" href="/peripheral_brain/css/diseases.css">
  


  <link href="https://fonts.googleapis.com/css?family=Open+Sans" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto+Slab" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto+Mono" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto+Condensed" rel="stylesheet">


  <link rel="apple-touch-icon" sizes="180x180" href="/peripheral_brain/favicons/apple-touch-icon.png">
  <link rel="icon" type="image/png" sizes="32x32" href="/peripheral_brain/favicons/favicon-32x32.png">
  <link rel="icon" type="image/png" sizes="16x16" href="/peripheral_brain/favicons/favicon-16x16.png">
  <link rel="manifest" href="/peripheral_brain/favicons/site.webmanifest">
  <link rel="mask-icon" href="/peripheral_brain/favicons/safari-pinned-tab.svg" color="#465c8b">
  <link rel="shortcut icon" href="/peripheral_brain/favicons/favicon.ico">
  <meta name="apple-mobile-web-app-title" content="Peripheral Brain">
  <meta name="application-name" content="Peripheral Brain">
  <meta name="msapplication-TileColor" content="#da532c">
  <meta name="msapplication-config" content="/peripheral_brain/favicons/browserconfig.xml">
  <meta name="theme-color" content="#cdcdcd">


  

</head>


<body class="body">
<header id="myHeader" class="myHeader">
  <nav>
    <!-- <a href="/peripheral_brain/home.html"><img src="/peripheral_brain/images/logo_1000x1000.png" alt="Logo"> -->
    <a href="/peripheral_brain/home.html">Home</a>
    <a href="/peripheral_brain/disease_list.html">Diseases and Drugs</a>
    <a href="/peripheral_brain/firstFive">TF5M</a>
    <a href="/peripheral_brain/lab_values">Lab Values</a>
    <a href="/peripheral_brain/formulas">Formulas</a>
    <a href="/peripheral_brain/literature.html">Literature</a>
    <a href="/peripheral_brain/abxCalc.html">Calculators</a>
    <a href="/peripheral_brain/search.html">Search</a>
    <a href="javascript:void(0);" class="icon" onclick="openMenu()">&#9776;</a>
  </nav>

  <script>
  function openMenu() {
      var x = document.getElementById("myHeader");
      if (x.className === "myHeader") {
          x.className += " responsive";
      } else {
          x.className = "myHeader";
      }
  }
  </script>
</header>


<h1 class="title">DM</h1>

<div class="contents twoCol">
  <div class="toc col1">
    
      <ul>
  <li><a href="#dx">Dx<sup id="fnref:adaDM2018"><a href="#fn:adaDM2018" class="footnote">1</a></sup></a></li>
  <li><a href="#tx-">Tx<sup id="fnref:adaDM2018:1"><a href="#fn:adaDM2018" class="footnote">1</a></sup><sup>, </sup><sup id="fnref:acceDM2018"><a href="#fn:acceDM2018" class="footnote">2</a></sup></a>
    <ul>
      <li><a href="#drugs">Drugs</a></li>
      <li><a href="#insulin">Insulin</a></li>
    </ul>
  </li>
  <li><a href="#dka">DKA</a></li>
  <li><a href="#references">References</a></li>
</ul>

    
  </div>

  <div class="content col2">
    <h1 id="dx">Dx<sup id="fnref:adaDM2018"><a href="#fn:adaDM2018" class="footnote">1</a></sup></h1>

<ul>
  <li>Any of the Following (for T2DM)
    <ul>
      <li>FBG ≥ 126 (8hr fasting)</li>
      <li>2hr-PPG ≥ 200 (75g GTT)</li>
      <li>A1C ≥ 6.5%</li>
      <li>SSx of DM w/ random BG ≥ 200</li>
    </ul>
  </li>
  <li>Pre-T2DM
    <ul>
      <li>FPG 100-125</li>
      <li>2hrPPG 140-199 (75g GTT)</li>
      <li>A1C 5.7-6.4%</li>
    </ul>
  </li>
  <li>Testing Criteria for DM
    <ul>
      <li>BMI ≥ 25 w/ 1 of the following risk factors
        <ul>
          <li>FHx of DM</li>
          <li>AA, Latino, Native America, Asian, Pacific Islander</li>
          <li>CVD</li>
          <li>HTN</li>
          <li>HDL &lt; 35 or TG &gt; 250</li>
          <li>PCOS</li>
          <li>Physical inactivity</li>
          <li>Other conditions indicating insulin resistance</li>
        </ul>
      </li>
      <li>Yearly test if A1C &gt; 5.7 (pre-diabetes)</li>
      <li>Hx of GDM should be tested Q3yrs</li>
      <li>Age ≥ 45yo</li>
    </ul>
  </li>
  <li>If all tests are normal, repeat Q3yr or earlier if clinically suspicious</li>
</ul>

<h1 id="tx-">Tx<sup id="fnref:adaDM2018:1"><a href="#fn:adaDM2018" class="footnote">1</a></sup><sup>, </sup><sup id="fnref:acceDM2018"><a href="#fn:acceDM2018" class="footnote">2</a></sup></h1>

<ul>
  <li>Monitoring
    <ul>
      <li>A1C at least twice yearly if meeting treatment goals</li>
      <li>A1C Q3mo if not meeting goals or changing regimens</li>
    </ul>
  </li>
  <li>ADA Goals
    <ul>
      <li>A1C &lt; 7</li>
      <li>FBG 80-130</li>
      <li>PPG &lt; 180</li>
    </ul>
  </li>
  <li>ACCE Goals
    <ul>
      <li>A1C ≤ 6.5</li>
    </ul>
  </li>
  <li>Prediabetes
    <ul>
      <li>Metformin 850mg QD x1mo then 850mg BID<sup id="fnref:lexi"><a href="#fn:lexi" class="footnote">3</a></sup></li>
    </ul>
  </li>
  <li>T2DM
    <ul>
      <li>Metformin is 1st line, all pts w/o CIs should be on metformin</li>
      <li>A1C &lt; 9%, initiate monotherapy</li>
      <li>A1C 9-10%, initiate dual therapy
        <ul>
          <li>Move to triple therapy if failure before moving to injectables</li>
        </ul>
      </li>
      <li>A1C ≥ 10%, initiate combination injectable therapy
        <ul>
          <li>Bolus or Premix BID or GLP-1 1st</li>
          <li>Then progress to combos or basal-bolus</li>
        </ul>
      </li>
    </ul>
  </li>
</ul>

<h2 id="drugs">Drugs</h2>

<ul>
  <li>Metformin
    <ul>
      <li>Yearly B12 levels</li>
      <li>Really Adjusted</li>
    </ul>
  </li>
  <li>SGLT2s
    <ul>
      <li>Renal adjustments with all</li>
      <li>Canagliflozin has increased amputation risk and fracture risk</li>
      <li><strong>Can cause normoglycemic DKA</strong></li>
      <li>Increased risk of UTI</li>
      <li>Canagliflozin and empagliflozin have CV benefit</li>
      <li>Higher LDL</li>
    </ul>
  </li>
  <li>GLP-1s
    <ul>
      <li>Liraglutide has some CV benefit</li>
      <li>Some have renal adjustments</li>
      <li>Risk of thyroid C-cell tumors</li>
      <li>Pancreatitis</li>
      <li>Significant GI SEs</li>
    </ul>
  </li>
  <li>DPP-4s
    <ul>
      <li>Some CHF risk</li>
      <li>Renal adjustments, but no renal CI</li>
      <li>Acute pancreatitis</li>
      <li>Joint pain</li>
    </ul>
  </li>
  <li>TZDs
    <ul>
      <li>Pioglitazone has ASCVD benefit and all have CHF risk</li>
      <li>No dose adjustments, but not recommended in renal impairment d/t fluid retention</li>
      <li>Fluid retention</li>
      <li>Bone fractures</li>
      <li>Bladder cancer (pioglitazone)</li>
      <li>Higher LDL</li>
    </ul>
  </li>
  <li>Sulfonylureas
    <ul>
      <li>No CV impacts
        <ul>
          <li>Older sulfonylureas have CV risk</li>
        </ul>
      </li>
      <li>Glyburide not recommended</li>
      <li>Glipizide and glimeperide should be started low w/ renal impairment</li>
    </ul>
  </li>
</ul>

<h2 id="insulin">Insulin</h2>

<ul>
  <li>T1DM Dosing
    <ul>
      <li>Initiate 0.4-1 U/kg QD as a basal-bolus regimine</li>
    </ul>
  </li>
  <li>T2DM Dosing
    <ul>
      <li>Initiate Basal 10 U QD or 0.1-0.2 U/kg QD</li>
      <li>Bolus 4 U, 0.1 U/kg, or 10% of basal</li>
      <li>Adjust by 10-15% or 2-4 U once or twice weekly</li>
      <li>If hypoglycemic with no other discernible cause, decrease dose by 4 U or 10-20%</li>
    </ul>
  </li>
</ul>

<h1 id="dka">DKA</h1>

<h1 id="references">References</h1>

<!-- Cardiology -->

<!-- ACS -->

<!-- HTN -->

<!-- VTE -->

<!-- CHF -->

<!-- HLD -->

<!-- EKG Interpretation -->

<!-- Critical Care -->

<!-- RSI -->

<!-- Hypotension Management -->

<!-- Stress Ulcer Prophylaxis -->

<!-- ID -->

<!-- Vancomycin Dosing -->

<!-- Aminoglycoside Dosing -->

<!-- Pulmononolgy -->

<!-- Endocrinology -->

<!-- Textbooks -->

<!-- Pharmacology -->

<!-- Emergency Medicine -->

<!-- Websites -->

<!-- Drug Resources -->

<div class="footnotes">
  <ol>
    <li id="fn:adaDM2018">
      <p>Professional Practice Committee: <em>Standards of Medical Care in Diabetes—2018</em>. <em>Diabetes Care</em>. 2018;41:S3-S3. doi:<a href="https://doi.org/10.2337/dc18-Sppc01">10.2337/dc18-Sppc01</a> <a href="#fnref:adaDM2018" class="reversefootnote">&#8617;</a> <a href="#fnref:adaDM2018:1" class="reversefootnote">&#8617;<sup>2</sup></a></p>
    </li>
    <li id="fn:acceDM2018">
      <p>Garber AJ, Abrahamson MJ, Barzilay JI, et al. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – <em>2018 EXECUTIVE SUMMARY</em>. <em>Endocrine Practice</em>. 2018;24(1):91-120. doi:<a href="https://doi.org/10.4158/CS-2017-0153">10.4158/CS-2017-0153</a> <a href="#fnref:acceDM2018" class="reversefootnote">&#8617;</a></p>
    </li>
    <li id="fn:lexi">
      <p>Lexi-Drugs. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Available at: <a href="http://online.lexi.com">http://online.lexi.com</a>. <a href="#fnref:lexi" class="reversefootnote">&#8617;</a></p>
    </li>
  </ol>
</div>

  </div>

</div>

<div class="credits">
  <p>Author: Corbin Cox <br>
  Created: 2018-12-28 <br>
  Last Updated: 2018-12-28</p>
</div>

<footer class="footer menus">
  <nav>
    <div class="footerLinks">
      <a href="/peripheral_brain/home.html">Home</a>
      <a href="/peripheral_brain/index.html">Disclaimer</a>
      <a href="/peripheral_brain/disease_list_old.html">Archived Diseases</a>
    </div>
  </nav>
</footer>


</body>
</html>
